机器人经肛微创手术(r-TAMIS):直肠癌局部切除的围手术期与短期结局
该回顾性分析纳入2021年7月至2023年7月前瞻性收集的r-TAMIS数据库中的20例早期直肠癌患者,评估机器人经肛微创手术局部切除的围手术期与短期肿瘤学结局。结果显示R0切除率90.0%,局部复发率5.0%,主要并发症率0%,结论认为在严格术后监测下r-TAMIS安全可行,可能适用于拒绝或无法耐受TME手术的高龄及手术 unfit 患者。
要点
- 20例早期直肠癌行r-TAMIS局部切除,中位手术时间90.0分钟,中位术后住院2.0天。
- R0切除率90.0%,主要并发症率0%,中位随访15.5个月局部复发率5.0%。
- 作者认为r-TAMIS在严格术后监测下安全可行,可能适用于拒绝或无法耐受TME的高龄及手术 unfit 患者。
核心结论
- 在严格术后监测下,r-TAMIS是早期直肠癌局部切除安全可行的方法,可能适用于拒绝或无法接受TME手术的手术 unfit 及高龄患者。
- 需要未来前瞻性多中心大规模研究来报告长期肿瘤学结局。
研究设计与样本
- 回顾性分析前瞻性收集的r-TAMIS数据库(2021年7月至2023年7月),共纳入20例早期直肠癌患者。
- 调查人口学资料、临床病理特征、短期结局、复发和生存情况。
主要发现
- 中位年龄69.5(62.0-77.7)岁,中位体质指数31.0(21.0-36.5)kg/m2,男性12例(60.0%),ASA III级占66.7%。
- 中位肿瘤距肛缘距离7.5(5.0-11.7)cm,中位手术时间90.0(60.0-112.5)分钟,失血量极少,无中转,中位术后住院2.0(1.0-3.0)天。
- 轻微并发症率25.0%,主要并发症率0%;17例(85.0%)为腺癌,3例为腺瘤。
- R0切除率90.0%;多数肿瘤为pT1(55.0%),其次为pT2(25.0%),1例(5.0%)为pT3。
- 标本最大径中位51.0(41.0-62.0)mm,肿瘤最大径中位21.5(17.2-42.0)mm,标本面积中位193.1(134.3-323.3)cm2。
临床怎么用
- 作者认为r-TAMIS在严格术后监测下可用于早期直肠癌局部切除,可能适用于拒绝或无法接受TME手术的手术 unfit 及高龄患者。
- 原文未据此给出其他推荐。
局限性
- 需要未来前瞻性多中心大规模研究来报告长期肿瘤学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transanal minimally invasive surgery (TAMIS) is an advanced technique for excision of early rectal cancers. Robotic TAMIS (r-TAMIS) has been introduced as technical improvement and potential alternative to total mesorectal excision (TME) in early rectal cancers and in frail patients. This study reports the perioperative and short-term oncological outcomes of r-TAMIS for local excision of early-stage rectal cancers. METHODS: Retrospective analysis of a prospectively collected r-TAMIS database (July 2021-July 2023). Demographics, clinicopathological features, short-term outcomes, recurrences, and survival were investigated. RESULTS: Twenty patients were included. Median age and body mass index were 69.5 (62.0-77.7) years and 31.0 (21.0-36.5) kg/m2. Male sex was prevalent (n = 12, 60.0%). ASA III accounted for 66.7%. Median distance from anal verge was 7.5 (5.0-11.7) cm. Median operation time was 90.0 (60.0-112.5) minutes. Blood loss was minimal. There were no conversions. Median postoperative stay was 2.0 (1.0-3.0) days. Minor and major complication rates were 25.0% and 0%, respectively. Seventeen (85.0%) patients had an adenocarcinoma whilst three patients had an adenoma. R0 rate was 90.0%. Most tumours were pT1 (55.0%), followed by pT2 (25.0%). One patient (5.0%) had a pT3 tumour. Specimen and tumour maximal median diameter were 51.0 (41.0-62.0) mm and 21.5 (17.2-42.0) mm, respectively. Median specimen area was 193.1 (134.3-323.3) cm2. Median follow-up was 15.5 (10.0-24.0) months. One patient developed local recurrence (5.0%). CONCLUSIONS: r-TAMIS, with strict postoperative surveillance, is a safe and feasible approach for local excision of early rectal cancer and may have a role in surgically unfit and elderly patients who refuse or cannot undergo TME surgery. Future prospective multicentre large-scale studies are needed to report the long-term oncological outcomes.
引用
- Piozzi GN, Przedlacka A, Duhoky R, et al. Robotic transanal minimally invasive surgery (r-TAMIS): perioperative and short-term outcomes for local excision of rectal cancers. Surg Endosc. 2024. PMID: 38710889. doi:10.1007/s00464-024-10829-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。